Apply to trial NCT07314294

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 2Drug trial

Phase II Study of EMB-01 in Recurrent/Metastatic Colorectal Cancer Patients

This study is testing different dosing schedules of EMB-01 in patients with advanced colorectal cancer whose disease has recurrent or progressed on previous treatments. Patients will be randomly assigned to one of two dosing schedules: EMB-01 once weekly, or once weekly for 6 weeks then every two weeks.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Phase II Study of EMB-01 in Recurrent/Metastatic Colorectal Cancer Patients

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening